Stay updated on PTI-801 Safety and Pharmacokinetics in CF Clinical Trial

Sign up to get notified when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:18:06.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the number of subjects to be enrolled in Part 1 of a clinical trial assessing the safety, tolerability, pharmacokinetics, food effect, and drug-drug interactions of PTI-801 in healthy volunteers.
    Difference
    0.1%
    Check dated 2024-06-06T14:51:06.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying age, BMI, smoking status, and various health conditions. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    27%
    Check dated 2024-05-22T21:32:56.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:40:03.000Z thumbnail image

Stay in the know with updates to PTI-801 Safety and Pharmacokinetics in CF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.